Exablate Neuro With GE SIGNA Premier MR System

    The Exablate Neuro is a focused ultrasound platform for treating deep in the brain with no surgical incisions.

    INSIGHTEC Submits Pre-market Approval to Japanese PMDA of MR-guided Focused Ultrasound Surgery for Treatment of Parkinson’s Disease

    5/14/18: "INSIGHTEC is committed to supporting research that extends the applications and potential of focused ultrasound, to improve the lives of people living with Parkinson's disease with a much less invasive approach than conventional surgery," commented Maurice R. Ferré MD, INSIGHTEC'S CEO and Chairman of the Board of Directors.

    INSIGHTEC Closes $150 Million Series E Financing

    1/31/18: INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MRI-guided focused ultrasound (MRgFUS) announced today the closing of a $150 million Series E private equity investment round. Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries, focused on finding and funding innovative and emerging companies, led the round with a $100 million investment.